150 related articles for article (PubMed ID: 38611082)
1. Transperineal Laser Ablation (TPLA) Treatment of Focal Low-Intermediate Risk Prostate Cancer.
Manenti G; Perretta T; Nezzo M; Fraioli FR; Carreri B; Gigliotti PE; Micillo A; Malizia A; Di Giovanni D; Ryan CP; Garaci FG
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611082
[No Abstract] [Full Text] [Related]
2. Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer.
Manenti G; Nezzo M; Ryan CP; Fraioli FR; Carreri B; Gigliotti PE; Angeloni C; Di Pietro F; De Angeli M; Perretta T; D'Angelillo RM; Garaci FG
BJR Open; 2023; 5(1):20230042. PubMed ID: 37942495
[TBL] [Abstract][Full Text] [Related]
3. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
4. Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging.
van Riel LAMJG; van Kollenburg RAA; Freund JE; Almasian M; Jager A; Engelbrecht MRW; Smit RS; Bekers E; Nieuwenhuijzen JA; van Leeuwen PJ; van der Poel H; de Reijke TM; Beerlage HP; Oddens JR; de Bruin DM
Eur Urol Open Sci; 2023 Aug; 54():72-79. PubMed ID: 37545846
[TBL] [Abstract][Full Text] [Related]
5. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up.
Mehralivand S; George AK; Hoang AN; Rais-Bahrami S; Rastinehad AR; Lebastchi AH; Ahdoot M; Siddiqui MM; Bloom J; Sidana A; Merino MJ; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA
Diagn Interv Radiol; 2021 May; 27(3):394-400. PubMed ID: 34003127
[TBL] [Abstract][Full Text] [Related]
6. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study.
van Kollenburg R; van Riel L; Bloemen P; de Reijke T; Beerlage H; de Bruin D; Oddens J
BJUI Compass; 2024 Jan; 5(1):52-59. PubMed ID: 38179027
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy.
Al-Hakeem Y; Raz O; Gacs Z; Maclean F; Varol C
ANZ J Surg; 2019 Dec; 89(12):1610-1614. PubMed ID: 31679182
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
Shah TT; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Grierson J; Miah H; Emara A; Haroon A; Latifoltojar A; Sidhu H; Clemente J; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra A; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU
Eur Urol; 2022 Jun; 81(6):598-605. PubMed ID: 35370021
[TBL] [Abstract][Full Text] [Related]
9. Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer.
Oderda M; Marquis A; Calleris G; D'Agate D; Faletti R; Gatti M; Marra G; Gontero P
Eur Urol Open Sci; 2022 Dec; 46():3-7. PubMed ID: 36304751
[TBL] [Abstract][Full Text] [Related]
10. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study.
van Riel LAMJG; van Kollenburg RAA; Vis AN; van Leeuwen PJ; de Reijke TM; de Bruin DM; Oddens JR
Eur Urol Open Sci; 2022 May; 39():48-54. PubMed ID: 35528781
[TBL] [Abstract][Full Text] [Related]
11. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia.
Manenti G; Perretta T; Calcagni A; Ferrari D; Ryan CP; Fraioli F; Meucci R; Malizia A; Iacovelli V; Agrò EF; Floris R
Eur Radiol Exp; 2021 Sep; 5(1):41. PubMed ID: 34532768
[TBL] [Abstract][Full Text] [Related]
12. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
[TBL] [Abstract][Full Text] [Related]
13. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
14. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
[TBL] [Abstract][Full Text] [Related]
15. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study.
Canat HL; Gurbuz C; Bozkurt M
Int Urol Nephrol; 2023 Nov; 55(11):2747-2752. PubMed ID: 37498422
[TBL] [Abstract][Full Text] [Related]
16. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
[TBL] [Abstract][Full Text] [Related]
17. Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.
Patelli G; Ranieri A; Paganelli A; Mauri G; Pacella CM
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1440-1446. PubMed ID: 28474112
[TBL] [Abstract][Full Text] [Related]
18. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.
Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA
Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811
[TBL] [Abstract][Full Text] [Related]
20. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia.
Zhang W; Zhang W; Guo Q; Chen L; Meng Z; Xu Y; Cao N; Hu B; Qian B
Front Surg; 2021; 8():755957. PubMed ID: 34733883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
